---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-042849"
form_type: "8-K"
ticker: "ERNA"
cik: "0000748592"
company_name: "Ernexa Therapeutics Inc."
filed_at: "2022-11-23T23:59:59+00:00"
generated_at: "2026-06-21T13:42:55.694761+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Eterna Therapeutics receives Nasdaq deficiency notice for insufficient stockholders' equity

## Summary
- Stockholders' equity ~$8.8M as of Sep 30, 2022, below $10M minimum for Nasdaq Global Market.
- Company has 45 days to submit a compliance plan; Nasdaq may grant up to 180-day extension.
- Company may also consider transferring its listing from Nasdaq Global Market to Nasdaq Capital Market.
- Notice has no immediate effect on listing; delisting risk if compliance not regained within prescribed timeline.

## SEC filing metadata
- accession: 0001140361-22-042849
- form_type: 8-K
- ticker: ERNA
- cik: 0000748592
- company_name: Ernexa Therapeutics Inc.
- filed_at: 2022-11-23T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/748592/000114036122042849/0001140361-22-042849-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/748592/000114036122042849/brhc10044625_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-042849
- JSON: https://secwatch.observer/filing/0001140361-22-042849.json
- Plain text: https://secwatch.observer/filing/0001140361-22-042849.txt

## Key facts
- Listing & Compliance Notices
  Ernexa Therapeutics Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5450(b)(1)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: stockholders equity
  - Rules: 5450(b)(1)(A)
  source text: November 22, 2022, Eterna Therapeutics Inc. (the “ Company ”) received a notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company’s stockholders’ equity of approximately $8.8 million, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, fails to comply with the minimum $10.0 million stockholders’ equity requirement for continued listing on the Nasdaq Global Market in accordance with Nasdaq Listing Rule 5450(b)(1)(A) (the “ Nasdaq Listing Rule ”). The Notice has no immediate effect on the listing of the Com
  evidence_url: https://www.sec.gov/Archives/edgar/data/748592/000114036122042849/0001140361-22-042849-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.